PharmExec

"Patients with DPYD variations are 25.6X more likely to experience treatment related death on standard‐dose fluoropyrimidine chemotherapy (5‐fluorouracil or capecitabine)." - Kristine Ashcraft, President and Founder of YouScript Read more about…